Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease

Archives of Neurology

Volumn 64, Issue 9, 2007, Pages 1312-1317

  Ikonomovic, Milos D ^a   Abrahamson, Eric E ^a   Isanski, Barbara A ^a   Wuu, Joanne ^b   Mufson, Elliott J ^b   DeKosky, Steven T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CHOLINE ACETYLTRANSFERASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC NERVE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL PLASTICITY; NERVE FIBER; NEUROPATHOLOGY; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; AXONS; CHOLINE O-ACETYLTRANSFERASE; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBERS; NEUROPSYCHOLOGICAL TESTS; PARASYMPATHETIC NERVOUS SYSTEM; PREFRONTAL CORTEX;

EID: 34548649848     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.9.1312     Document Type: Article

References (30)

1. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J. 1978;2(6150):1457-1459.
2. Wilcock GK, Esiri MM, Bowen DM, Smith CC. Alzheimer's disease: correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci. 1982;57(2-3):407-417.
3. Bierer LM, Haroutunian V, Gabriel S, et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem. 1995;64(2):749-760.
4. Dournaud P, Delaere P, Hauw JJ, Eppelbaum J. Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's Disease. Neurobiol Aging. 1995;16(5):817-823.
5. Davis KL, Mohs RC, Marin D, et al. Cholinergic markers in elderly patients with early signs of Alzheimer's disease. JAMA. 1999;281(15):1401-1406.
6. Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J. The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. Neurology. 2000;55(9):1278-1283.
7. DeKosky ST, Ikonomovic MD, Styren S, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002;51(2):145-155.
8. Counts SE, Nadeem M, Lad S, Wuu J, Mufson EJ. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol. 2006;65(6):592-601.
9. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59(2):198-205.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
11. Mufson EJ, Ma SJ, Cochran EJ, et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 2000;427(1):19-30.
12. Mufson EJ, Ma SY, Dills J, et al. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002;443(2):136-153.
13. Braak H, Braak E. Neuropathological staging of Alzheimer's disease. Acta Neuropathol (Berl). 1991;82(4):239-259.
14. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease: a primer for practicing pathologists. Arch Pathol Lab Med. 1993;117(2):129-131.
15. Ikonomovic MD, Mizukami K, Davies P, Hamilton R, Sheffield R, Armstrong DM. The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains. J Neuropathol Exp Neurol. 1997;56(9):1018-1027.
16. Mufson EJ, Bothwell M, Hersh LB, Kordower JH. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J Comp Neurol. 1989;285(2):196-217.
17. Gilmor ML, Erickson JD, Varoqui H, et al. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 1999;411(4):693-704.
18. Mesulam MM, Hersh LB, Mash DC, Geula C. Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study. J Comp Neurol. 1992;318(3):316-328.
19. DeKosky ST, Scheff SW, Markesbery WR. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging. Neurology. 1985;35(10):1425-1431.
20. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex, I: remapping of the areas 9 and 46 using quantitative criteria. Cereb Cortex. 1995;5(4):307-322.
21. Howard CV, Reed MG. Unbiased Stereology: Three-Dimensional Measurement in Microscopy. Oxford, England: BIOS Scientific Publishers Ltd; 1998.
22. Mesulam MM, Geula C. Chemoarchitectonics of axonal and perikaryal acetylcholinesterase along information processing systems of the human cerebral cortex. Brain Res Bull. 1994;33(2):137-153.
23. Houser CR. Cholinergic synapses in the central nervous system: studies of the immunocytochemical localization of choline acetyltransferase. J Electron Microsc Tech. 1990;15(1):2-19.
24. Smiley JF, Morrell F, Mesulam MM. Cholinergic synapses in human cerebral cortex: an ultrastructural study in serial sections. Exp Neurol. 1997;144(2):361-368.
25. Slotkin TA, Nemeroff CB, Bissette G, Seidler FJ. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease: evidence from rapid autopsy studies. J Clin Invest. 1994;94(2):696-702.
26. Dubelaar EJ, Mufson EJ, ter Meulen WG, Van Heerikhuize JJ, Verwer RW, Swaab DF. Increased metabolic activity in nucleus basalis of Meynert neurons in elderly individuals with mild cognitive impairment as indicated by the size of the Golgi apparatus. J Neuropathol Exp Neurol. 2006;65(3):257-266.
27. Gaykema RP, Nyakas C, Horvath E, Hersh LB, Majtenyi C, Luiten PG. Cholinergic fiber aberrations in nucleus basalis lesioned rat and Alzheimer's disease. Neurobiol Aging. 1992;13(3):441-448.
28. Stokin GB, Lillo C, Falzone TL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science. 2005;307(5713):1282-1288.
29. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment [published online ahead of print April 13, 2005]. N Engl J Med. 2005;352(23):2379-2388.
30. Tuszynski MH, Blesch A. Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. Prog Brain Res. 2004;146:441-449.